Ruth Holm

Experimental Pathology

Group Leader: Ruth Holm Ph.D.

The research work of our group include gynaecological cancers and cell cycle-, apoptosis- and cell adhesion-markers, matrix metalloproteinases and HPV.

In addition to our own projects we are doing research work for other departments at Rikshospitalet-Radiumhospitalet Medical Center (RRMC) as well as for other hospitals.

Research projects

Molecular mechanisms in development and progression of ovarian cancers.

Molecular mechanisms in development and progression of vulvar cancers.

Print this page [459 visits]

News & events

Kick-off seminar at Montebello on June 21st:
Focus on recruitment and career building in health research
May 24, 2013

A newly identified protein regulates cell division
May 21, 2013

The story of PCI popularized and presented in national media
May 14, 2013

Publication in Nature Genetics on testicular cancer susceptibility
May 13, 2013

Institute seminar May 8th
Gunnar Kvalheim
May 6, 2013

More news

Latest publications

Ruth Holm

Holm R, Førsund M, Nguyen MT, Nesland JM, Trope CG (2013)
Expression of p15(INK4b) and p57(KIP2) and Relationship with Clinicopathological Features and Prognosis in Patients with Vulvar Squamous Cell Carcinoma
PLoS One, 8 (4), e61273
PubMed 23580324

Sigstad E, Paus E, Bjøro T, Berner A, Grøholt KK, Jørgensen LH, Sobrinho-Simões M, Holm R, Warren DJ (2013)
Reply to 'The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors'
Mod Pathol, 26 (4), 613-5
PubMed 23542526

Revheim ME, Kristian A, Malinen E, Bruland ØS, Berner JM, Holm R, Joensuu H, Seierstad T (2013)
Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H
Acta Oncol, 52 (4), 776-82
PubMed 23480638

More publications